Фомин И. В.

Российский кардиологический журнал, Journal Year: 2016, Volume and Issue: №8, P. 7 - 13, https://doi.org/10.15829/1560-4071-2016-8-7-13

Published: Aug. 1, 2016

Latest article update: Oct. 13, 2022

Представлен анализ трех эпидемиологических исследований (ЭПОХА-ХСН, ЭПОХА-Госпиталь-ХСН и ЭПОХА-Декомпенсация-ХСН). За 16 лет в РФ распространенность хронической сердечной недостаточности (ХСН) выросла достоверно от 4,9% (1998г) до 10,2% (2014г), р-0,01. При этом число пациентов с ХСН ІІІ-ІѴ ФК увеличилось значительнее: от 1,2% (1998г) до 4,1% (2014г), р-0,002. Это произошло за счет достоверного увеличения возраста выборки больных с 64,0±11,9 лет (1998г) по 69,9±12,2 лет (2014г), р-0,02; увеличения весомости этиологических причин ишемической болезни сердца и перенесенного инфаркта миокарда. Общая смертность больных любого ХСН составляет 6% в год. Показатель зависит от низкой частоты назначений блокаторов РААС и бета-блокаторов на амбулаторном этапе с использованием низких доз …

Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment DOI Creative Commons
Mareev VIu, И. В. Фомин, Ф. Т. Агеев

et al.

Kardiologiia, Journal Year: 2018, Volume and Issue: 17(S6), P. 1 - 164

Published: Jan. 1, 2018

Language: Английский

Citations

338

2020 Clinical practice guidelines for Chronic heart failure DOI Creative Commons

Russian Society of Cardiology

Russian Journal of Cardiology, Journal Year: 2020, Volume and Issue: 25(11), P. 4083 - 4083

Published: Dec. 5, 2020

Endorsed by the Research and Practical Council of Ministry Health Russian Federation.

Language: Английский

Citations

333

Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study DOI Creative Commons
D. S. Polyakov, И. В. Фомин, Yu. N. Belenkov

et al.

Kardiologiia, Journal Year: 2021, Volume and Issue: 61(4), P. 4 - 14

Published: May 6, 2021

Aim To study the etiology and dynamics of prevalence mortality CHF; to evaluate treatment coverage such patients in a representative sample European part Russian Federation for 20-year period. Material methods A followed up 2002 through 2017 (n=19 276); population Nizhny Novgorod region examined 1998 (n=1922). Results During observation period since 2002, incidence major CHF symptoms (tachycardia, edema, shortness breath, weakness) tended decrease while cardiovascular diseases has statistically significantly increased. from 2017, I-IV functional class (FC) increased 6.1 % 8.2 whereas III-IV FC 1.8 3.1 %. The main causes development remained arterial hypertension ischemic heart disease; role myocardial infarction diabetes mellitus as was noted. For analyzed period, number components basic therapy with increased, which probably accounts slower increase disease by 2007–2017. prognosis unfavorable: I-II CHF, median survival 8.4 (95 CI: 7.8–9.1) years 3.8 3.4–4.2) years.

Language: Английский

Citations

160

2020 Clinical practice guidelines for Chronic heart failure DOI Creative Commons

Russian Society of Cardiology

Russian Journal of Cardiology, Journal Year: 2020, Volume and Issue: 25(11), P. 4083 - 4083

Published: Dec. 5, 2020

Endorsed by the Research and Practical Council of Ministry Health Russian Federation.

Language: Английский

Citations

88

Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation "PRIORITET-CHF": initial characteristics and treatment of the first included patients DOI Creative Commons
Е. V. Shlyakhto, Yu. N. Belenkov, S. А. Boytsov

et al.

Russian Journal of Cardiology, Journal Year: 2023, Volume and Issue: 28(10), P. 5593 - 5593

Published: Sept. 5, 2023

Aim. To describe demographic and clinical laboratory characteristics, concomitant diseases drug therapy of outpatients with heart failure (HF) in the Russian Federation. Material methods. An interim analysis a prospective observational multicenter registry study patients chronic Federation ("PRIORITET-CHF") was performed. The included HF followed by general practitioner or cardiologist. Results. Data from 6255 were analyzed (31,3% sample; median age, 65 years; men, 65%). reduced ejection fraction (HFrEF) diagnosed 42,4%, preserved EF — 31,9%. In addition, 57,4% characterized NYHA class II HF. most common causes hypertension, coronary artery disease, atrial fibrillation flutter. Of diseases, doctors often reported kidney disease (CKD) (43,2%), obesity (37,8%) diabetes (26,7%) Conclusion. Federation, among HF, there domination HFrEF phenotype, II. relatively young mean age frequent associations cardiovascular risk factors underscore importance timely prevention initiatives. identified high proportion CKD requires special attention separate analysis. Despite prescription rate certain classes diseasemodifying for optimal quadruple electrophysiological treatments is insufficient.

Language: Английский

Citations

25

Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines DOI Creative Commons
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина

et al.

CARDIOVASCULAR THERAPY AND PREVENTION, Journal Year: 2024, Volume and Issue: 23(3), P. 3696 - 3696

Published: April 1, 2024

Создание руководства поддержано Советом по терапевтическим наукам отделения клинической медицины Российской академии наук.

Language: Русский

Citations

14

Analysis of mortality in patients with heart failure after de­compen­sation during long-term follow-up in specialized medical care and in real clinical practice DOI Creative Commons
Н. Г. Виноградова, D. S. Polyakov, И. В. Фомин

et al.

Kardiologiia, Journal Year: 2020, Volume and Issue: 60(4), P. 91 - 100

Published: May 4, 2020

Background Mortality from chronic heart failure (CHF) remains high and entails serious demographic losses worldwide. The most vulnerable group is patients after acute decompensated HF (ADHF) who have a risk of unfavorable outcome.Aim To analyze risks all-cause death (ACD), cardiovascular (CVD), recurrent ADHF in CHF during two years following long-term follow-up with specialized medical care real-life clinical practice.Material methods study successively included 942 ADHF. 510 continued out-patient treatment center (CHFTC) (group 1) 432 refused the management CHFTC were managed clinics at place patient's residence 2). Causes determined based on inpatient hospital records, postmortem reports, or outpatient records. Cases ACD, CVD, ADHF, composite index (CVD ADHF) analyzed. Statistical analysis was performed software package Statistica 7.0 for Windows, SPSS, statistical R.Results Patients 2 older, more frequently had functional class (FC) III less FC I compared to 1. Women preserved left ventricular ejection fraction (LV EF) prevailed both groups. Results Cox proportional hazards model mortality showed that belonging an independent predictor increased (р<0.001). An increase CCS score by 1 also Baseline LV EF did not influence any model. Female gender higher value 6-min walk test (6MW) independently decreased all outcomes except CVD. systolic BP 10 mm Hg reduced fatal outcomes. At groups 1, ACD 29.9 % 10.2 %, (OR, 3.7; 95 CI: 2.6-5.3; p <0.001), CVD 10.4 1.9 5.9; 2.8-12.4; p<0.001), 18.1 6.0 3.5; 2.2-5.5; 25.2 7.7 4.1; 2.7-6.1; р<0.001). Analysis period (3 6 months years) difference between outcome maximal first months.Conclusion system reduces discharge vulnerability impaired prognosis whereas baseline Protective factors female values 6MW BP.

Language: Английский

Citations

48

Socio-economic impact of heart failure in Russia DOI Creative Commons
О. М. Драпкина, S. А. Boytsov, V. V. Оmelyanovskiy

et al.

Russian Journal of Cardiology, Journal Year: 2021, Volume and Issue: 26(6), P. 4490 - 4490

Published: July 16, 2021

Heart failure (HF) significantly worsens the patient quality of life and leads to disability their significant part, as well increases risk death, which in turn causes economic damage. Aim . To assess annual socio-economic impact HF Russia. Material methods HF, a model was developed, assessed number patients seeking medical care (data from epidemiological studies), those with disabilities mortality rate among them. We also evaluated costs drug therapy government procurement reports) hospitalization compulsory health insurance tariffs), social benefits due disability, death on gross domestic product. Data prescription rate, hospitalizations obtained Russian registries cardiovascular diseases. Using foreign study, family caregiving were calculated. Results According modeling data, there are 7,1 million people In this case, context spending, is RUB 81,86 billion, including 18,6 direct nonmedical 47,1 indirect 16,2 billion. The 72,4 structure expenses, 73,6% costs, while main borne by patients, since only part them (19,6%) receive necessary medications within assistance programs. reduced ejection fraction, 56% higher than preserved fraction. Conclusion burden state. Improving healthcare system for category preferential provision, will reduce HF-related mortality, and, accordingly, state society.

Language: Английский

Citations

39

2024 Clinical practice guidelines for Chronic heart failure DOI Creative Commons
А. S. Galyavich,

S. N. Tereshchenko,

T. M. Uskach

et al.

Russian Journal of Cardiology, Journal Year: 2024, Volume and Issue: 29(11), P. 6162 - 6162

Published: Oct. 24, 2024

Russian Society of Cardiology (RSC) With the participation: National Myocardial Diseases and Heart Failure, Failure Specialists, Scientific Medical Internal Medicine Endorsed by Research Practical Council Ministry Health Federation (12.09.2024)

Language: Английский

Citations

5

Clusters of patients with chronic heart failure based on the analysis of body composition parameters and palliative status DOI Creative Commons
V. I. Shevtsova, Anna A. Pashkova, А. Н. Шевцов

et al.

Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH), Journal Year: 2025, Volume and Issue: 15(1), P. 72 - 78

Published: March 20, 2025

The aim of the study : to divide a heterogeneous group patients with chronic heart failure, taking into account parameters body composition and severity painful symptoms. Object methods . involved 298 CHF. was assessed: presence sarcopenia obesity (with calculation muscle mass index), functional class, left ventricular ejection fraction, markers galectin-3, hsCRP sodium uretic peptide, Bartel index. A 10-point Edmont scale used assess two-stage cluster analysis performed. Results Three clusters were identified in patient structure: share first overall structure 23.2%, second – 61.1%, third 15.8%. It determined that includes sarcopenic obesity. They are characterized by maximum galectin level fraction sample. have low walking speed, dynamometry, NТ-proBNP. intermediate position is occupied (patients isolated disorder or without it). high dynamometry indicators, 6-minute test value, Barthel Patients people weight sarcopenia. Sarcopenia Fast questionnaire T6W indicators significantly reduced fractions NТ-proBNP level. most pronounced pain fatigue lowest depression. In cluster, pain, fatigue, drowsiness, nausea, shortness breath, anxiety, well-being expressed much less than other clusters. And highest appetite disorders, depression, deterioration well-being. Conclusions distressing symptoms varies depending on and, accordingly, patient's composition, which can be constructing algorithms for providing palliative care

Language: Английский

Citations

0